These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 18634770

  • 1. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ, Qin XW, Yang XC, Li ZC, Zeng HS, Xu B, Gao Z, Wu YJ, Zhang X, Zhang CY.
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C, DIABETES Investigators.
    Eur Heart J; 2007 Aug 20; 28(16):1946-52. PubMed ID: 17562666
    [Abstract] [Full Text] [Related]

  • 7. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study).
    Rahel BM, Laarman GJ, Kelder JC, Ten Berg JM, Suttorp MJ.
    Am Heart J; 2009 Jan 20; 157(1):149-55. PubMed ID: 19081412
    [Abstract] [Full Text] [Related]

  • 8. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2423-31. PubMed ID: 17174178
    [Abstract] [Full Text] [Related]

  • 9. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J, Bavry AA, Rajagopal V, Henderson MR, Ellis SG, Brener SJ.
    Am J Cardiol; 2006 Sep 01; 98(5):616-8. PubMed ID: 16923447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C.
    Cardiology; 2008 Sep 01; 111(4):270-6. PubMed ID: 18451644
    [Abstract] [Full Text] [Related]

  • 17. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions.
    Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi F, Carlino M, Melzi G, Sangiorgi GM, Corvaja N, Colombo A.
    Eur Heart J; 2005 Jun 01; 26(11):1056-62. PubMed ID: 15817605
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H, Helqvist S, Thuesen L, Kløvgaard L, Jørgensen E, Saunamäki K, Krusell LR, Bøtker HE, Engstrøm T, Jensen GV, SCANDSTENT investigators.
    Am Heart J; 2006 Nov 01; 152(5):882-6. PubMed ID: 17070149
    [Abstract] [Full Text] [Related]

  • 19. Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.
    Li JJ, Yan HB, Xiang XP, Qin XW, Zhang CY.
    Cardiovasc Drugs Ther; 2009 Apr 01; 23(2):137-43. PubMed ID: 19016317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.